The hepatitis vaccine market is estimated to be valued at US$ 8.39 Billion in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The hepatitis vaccine market involves manufacturing of vaccines that prevent hepatitis A, hepatitis B, and hepatitis E. The hepatitis vaccines...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian